Experimental therapeutic reduces advanced-stage influenza viral loads faster than current therapies in preclinical study
by Steve Martin,Purdue UniversityAn Eradivir employee conducts research on the company's EV25 influenza therapeutic. Research published inProceedings of the National Academy of Science
Updated on: November 29,2024
Experimental therapeutic reduces advanced-stage influenza viral loads faster than current therapies in preclinical study
by Steve Martin,Purdue UniversityAn Eradivir employee conducts research on the company's EV25 influenza therapeutic. Research published inProceedings of the National Academy of Science
Updated on:November 29,2024
